Article
Progress of research on γδ T cells in colorectal cancer (Review)
4 Oct 2024
Abstract excerpt
Colorectal cancer (CRC) ranks as the third most prevalent malignancy and second leading cause of cancer‑related fatalities worldwide. Immunotherapy alone or in combination with chemotherapy has a favorable survival benefit for patients with CRC. Unlike αβ T cells, which are prone to drug resistance, γδ T cells do not exhibit major histocompatibility complex restriction and can target tumor cells through diverse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
